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Abstract
Since its incursion into North America in 1999, West Nile virus (WNV) has spread rapidly
across the continent resulting in numerous human infections and deaths. Owing to the absence
of an effective diagnostic test and therapeutic treatment against WNV, public health officials have
focussed on the use of preventive measures in an attempt to halt the spread of WNV in humans.
The aim of this paper is to use mathematical modelling and analysis to assess two main anti-WNV
preventive strategies, namely: mosquito reduction strategies and personal protection. We propose
a single-season ordinary differential equation model for the transmission dynamics of WNV in a
mosquito–bird–human community, with birds as reservoir hosts and culicine mosquitoes as vectors.
The model exhibits two equilibria; namely the disease-free equilibrium and a unique endemic
equilibrium. Stability analysis of the model shows that the disease-free equilibrium is globally
asymptotically stable if a certain threshold quantity (R0), which depends solely on parameters
associated with the mosquito–bird cycle, is less than unity. The public health implication of this
is that WNV can be eradicated from the mosquito–bird cycle (and, consequently, from the human
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population) if the adopted mosquito reduction strategy (or strategies) can make R0 < 1. On the
other hand, it is shown, using a novel and robust technique that is based on the theory of monotone
dynamical systems coupled with a regular perturbation argument and a Liapunov function, that if
R0 > 1, then the unique endemic equilibrium is globally stable for small WNV-induced avian
mortality. Thus, in this case, WNV persists in the mosquito–bird population.
© 2005 Society for Mathematical Biology. Published by Elsevier Ltd. All rights reserved.
1. Introduction
West Nile virus (WNV) is an arbovirus and a single-stranded RNA virus of the genus
Flavivirus and the family Flaviviridae first isolated in the West Nile district of Uganda
in 1937 (Smithburn et al., 1940). The virus, which is transmitted to humans and other
animals by female mosquitoes that have fed from the blood of infected birds, has spread
in Africa, Europe, the Middle East, west and central Asia, Oceania (subtype Kunjin), and
most recently, North America (Campbell et al., 2002; Centers for Disease Control and
Prevention, 2002a; Chowers et al., 2001; Nash et al., 2001; Petersen and Marfin, 2002).
Since its first incursion into North America in 1999 (Nash et al., 2001), numerous
cases of WNV infections in humans have been recorded in the USA (62 cases in 1999, 21
cases in 2000, 66 cases in 2001 and 4000 cases in 2002) (Centers for Disease Control and
Prevention, 2002c; Petersen et al., 2003). The large outbreak in 2002, which occurred in the
Ohio and Mississippi River basins, resulted in 284 deaths (Centers for Disease Control and
Prevention, 2002b). In Canada, following the first detection of WNV in birds in Ontario
in the year 2001, 400 human cases of WNV were reported in Ontario and Quebec in 2002
(Drebot et al., 2003; Petersen et al., 2003). In 2003, WNV accounted for at least 7021
human infections (probable and/or confirmed cases) and 152 deaths in the USA (Centers
for Disease Control and Prevention, 2003c) and 1240 infections and 10 deaths in Canada
(Health Canada, 2003c). The West Nile virus is sustained and amplified in an enzootic
cycle involving birds as reservoir hosts and female mosquitoes primarily of the genus Culex
as the vectors.
WNV is known to be predominantly spread to humans and other animals via mosquito
bites. However, there is now evidence showing WNV transmission through blood
transfusions, organ/tissue transplants, needle stick injury, exposure to infected laboratory
specimen and mother-to-child transmission (Bender and Thompson, 2003; Centers for
Disease Control and Prevention, 2002d,e,f; Health Canada, 2003a; Nosal and Pellizzari,
2003). Fortunately, there is no evidence suggesting human infection by touching or kissing
a WNV-infected individual, or from being around a health-care worker who has treated an
infected person. Likewise, there is no evidence to date that the virus can pass from infected
animals (horses, pets, etc.) to humans (Health Canada, 2003a).
Although many WNV-infected people (≈80%) remain asymptomatic, and some
(≈20%) show mild flu-like symptoms such as fever, headache, body aches, nausea,
vomiting etc., 1 in 150 infected individuals (mostly immuno-compromised and/or the
elderly) develop severe illness. Such severe symptoms, which typically last for several
weeks, include high fever, headache, meningitis, encephalitis, disorientation, coma,
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tremors, convulsions, muscle weakness, vision loss, numbness and paralysis (Centers for
Disease Control and Prevention, 2003a; Health Canada, 2003b).
Unfortunately, a specific treatment for WNV infection is yet to be found. People with
mild symptoms often recover on their own. In more severe cases, people usually need to go
to hospital where they can receive supportive treatment including intravenous fluids, help
with breathing and nursing care. Owing to its global spread and the associated morbidity
and mortality it inflicts (Chowers et al., 2001; Nash et al., 2001; Pepperell et al., 2003;
Petersen and Marfin, 2002), much attention has been focussed on devising methods for
controlling the spread of WNV in humans.
In the absence of effective anti-WNV therapeutic treatment and vaccine, WNV control
strategies are based on taking appropriate preventive measures. These measures include
mosquito reduction mechanisms and personal protection against exposure to mosquitoes.
Mosquito reduction mechanisms entail the elimination of mosquito breeding sites (such as
clearing culverts, roadside ditches etc., eliminating standing water), larvaciding (killing
of larvae before they become adults) and adulticiding (killing of adult mosquitoes by
spraying). On the other hand, personal protection is based on preventing vector mosquitoes
from biting humans (by using mosquito repellents, avoiding locations where mosquitoes
are biting and using barrier methods such as window screens and long-sleeved clothing)
(Nosal and Pellizzari, 2003; Petersen et al., 2003).
The literature on the mathematical modelling of the transmission of WNV is rather
scant; we cite two papers. Thomas and Urena (2001) formulate a difference equation
model for WNV targeting its effects on New York City, and determine the amount of
spraying (killing the mosquitoes) needed to eliminate the virus. Wonham et al. (2004)
present a single-season ordinary differential equation model for WNV transmission in the
mosquito–bird population. Their study, using local stability results and simulations, shows
that while mosquito control decreases WNV outbreak threshold, bird control increases
it. The aim of our study is to use mathematical modelling to gain some insights into
the transmission dynamics of WNV in the mosquito–bird–human population within a
single WNV season (from spring to fall) and to assess the aforementioned preventive
strategies. Details of the transmission cycle of WNV are given in Section 2. These guide
in the formulation in Section 3 of a deterministic ordinary differential equation model,
which monitors the interaction of various mosquitoes, birds and human subpopulations. By
investigating the qualitative features of this model, an important epidemiological threshold,
known as the basic reproduction number (Anderson and May, 1991), is determined in
Section 4. Global stability analyses of the associated equilibria are carried out in Section
4 and Appendix C. Simulation results are presented in Section 5, and Section 6 contains a
summary.
2. Transmission of West Nile virus
WNV is transmitted from bird to bird by mosquitoes, which become carriers when
they bite infected birds (Bender and Thompson, 2003; Centers for Disease Control and
Prevention, 2003b; Petersen et al., 2003). Infected mosquitoes carry the virus in their
salivary glands and infect susceptible bird species when taking a blood meal. The infected
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birds sustain a significant level of virus in the bloodstream for one to four days after
infection, during which time they may transmit the virus to subsequent feeding mosquitoes,
continuing the life cycle. After about four days, the bird hosts develop life-long immunity
to further West Nile infection (although a small number will succumb to the disease and
die). The virus has been found in more than 110 bird species (Bender and Thompson,
2003). Although some of these species may have no obvious signs of illness when infected,
others, such as crows, blue and grey jays, magpies and ravens, get sick more often and can
die (Health Canada, 2003a). For this reason, the sightings of dead crows have been used in
Canada as a marker for WNV activity, and the testing of dead crows for WNV remains a
crucial part of the WNV surveillance system (Nosal and Pellizzari, 2003). When infected
with WNV, many of the aforementioned avian species develop transient high-titre viremias
that should allow transmission of the virus to feeding mosquitoes (Work et al., 1955).
Although WNV infection has been recorded in at least 29 different species of
mosquitoes in North America (Bender and Thompson, 2003), it is most common in species
that feed on birds. Examples include mosquitoes from the Culex genus (the principal
maintenance and amplifying vectors of WNV) such as Culex pipiens, Culex restuans
and Culex tarsalis (Bender and Thompson, 2003; Health Canada, 2003a; Petersen et al.,
2003). Different types of mosquitoes are responsible for WNV infection in humans. These
include the “bridging” species which feed on both birds and humans (such as Coquillettidia
perturbans) and human biters (such as Aedes vexans) (Petersen et al., 2003).
In temperate regions, adult mosquitoes begin to emerge in the spring after under-
going the three aquatic stages (egg, larva, pupa). The ensuing viral replication in the
mosquito–bird–mosquito cycle, which continues until early fall, is affected by environ-
mental factors such as climate, host and vector predators and parasites, and host immune
status (Petersen et al., 2003). In the tropics, the incidence of WNV infections is greatest
during the rainy season when mosquitoes are most abundant (Campbell et al., 2002).
In the USA, nine mammalian species (humans, horses, cats, rabbits, skunks, squirrels,
chipmunks and two species of bats) were found to be naturally infected with WNV (Komar,
2000; Marfin et al., 2001). Furthermore, nearly all human infections with WNV result from
mosquito bites. It is known that WNV-infected humans and horses do not often develop an
infectious level of viremia, and are likely dead-end hosts (Campbell et al., 2002; Centers
for Disease Control and Prevention, 2003b). Human-to-human or non-human-vertebrate-
to-human transmission of WNV has not been documented.
3. Model formulation
The model is based on monitoring the temporal dynamics of the populations of
uninfected female mosquitoes Mu(t), infected female mosquitoes Mi (t), uninfected birds
Bu(t), infected birds Bi (t), susceptible humans S(t), asymptomatically infected humans
E(t), symptomatically infected humans I (t), hospitalized WNV-infected humans H (t)
and recovered humans R(t) as described in the following subsections. Here, NM =
Mu (t) + Mi (t) is the total population of female mosquitoes in the community, NB =
Bu(t) + Bi(t) is the total population of birds in the community and NH = S(t) + E(t) +
I (t) + H (t)+ R(t) is the total human population. A schematic description of the model is
depicted in Fig. 1.
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Fig. 1. Flow chart of the model.
3.1. Uninfected and infected female mosquitoes
The uninfected female mosquito population is increased via the birth or immigration of
uninfected (susceptible) mosquitoes at a constant rate ΠM . It is diminished by infection,
which may be acquired when uninfected mosquitoes feed from the blood of infected birds,
and by natural death (due to their finite lifespan) at a rate µM . The flow can be represented
using the differential equation
dMu
dt
= ΠM − b1(NM , NB , NH )β1 Mu BiNB − µM Mu , (1)
where b1(NM , NB , NH ) is the per capita biting rate of mosquitoes on the primary host
(birds), β1 is the probability of West Nile transmission from infected birds to uninfected
mosquitoes. Since mosquitoes bite both birds and humans, it is plausible to assume
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that the average number of mosquito bites received by birds and humans depends on
the total sizes of the populations of mosquitoes, birds and humans in the community.
Consequently, we define the mosquito biting rate to be a function of these total populations
(that is, b1 = b1(NM , NB , NH )). Here, cross-infection between birds and mosquitoes is
modeled using mass action incidence (Brauer and Castillo-Chavez, 2000; Hethcote, 2000)
normalized by total bird population (see also Wonham et al., 2004; Anderson and May,
1991, pp. 394–395).
The infected female mosquito population is generated via the infection of uninfected
mosquitoes by infected birds and diminished by natural death (at rate µM ). It is assumed
that infected mosquitoes do not recover before they die naturally, and that these mosquitoes
do not die of WNV. Furthermore, it is assumed that vertical transmission in mosquitoes is
negligible (and therefore omitted). Thus,
dMi
dt
= b1(NM , NB , NH )β1 Mu Bi
NB
− µM Mi . (2)
3.2. Uninfected and infected birds
The population of uninfected birds is increased via the recruitment of uninfected birds
(either by birth or immigration) at a rate ΠB . It is reduced by infection acquired when
uninfected birds are bitten by a WNV-carrying mosquito, and natural death (at a rate µB ).
Thus,
dBu
dt
= ΠB − b1(NM , NB , NH )β2 Mi BuNB − µB Bu, (3)
where β2 is the probability of WNV transmission from mosquitoes to birds.
The population of infected birds is generated by infection of uninfected birds following
contact with infected mosquitoes. It is diminished by natural death (at rate µB) and by
WNV-induced death (at a rate dB). This model assumes horizontal transmission from
infected birds to susceptible birds is negligible (Langevin et al., 2001; MClean et al., 2001;
Nasci et al., 2001; Turell et al., 2001; Wonham et al., 2004). This gives
dBi
dt
= b1(NM , NB , NH )β2Mi Bu
NB
− µB Bi − dB Bi . (4)
3.3. Susceptible and infected humans
The population of susceptible humans is increased via recruitment of humans (by
birth or immigration) into the community at a constant rate ΠH . It is decreased infection
(acquired via contact with infected mosquitoes) and by natural death (at a rate µH ). This
gives
dS
dt
= ΠH − b2(NM , NB , NH )β3 Mi SNH − µH S, (5)
where b2(NM , NB , NH ) is the per capita rate of biting of humans by mosquitoes and β3
is the probability of WNV transmission from mosquitoes to humans. Here, it is assumed
that new human infections are acquired at a rate that depends on the average number of
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mosquito bites per unit time and on the transmission probability normalized by total human
population (see also Anderson and May, 1991, pp. 394–395).
It is assumed that all newly WNV-infected humans are in the asymptomatic phase. The
population of asymptotically infected humans is decreased due to natural death (at rate
µH ) and development of symptoms (at a rate α). Thus,
dE
dt
= b2(NM , NB , NH )β3 Mi S
NH
− µH E − αE . (6)
Asymptomatically infected individuals are assumed to develop symptoms (and move
into the I (t) population) following the typical 2–14 days of incubation (Campbell et al.,
2002; Petersen et al., 2003). The symptomatic population is decreased by natural death (at
rate µH ) and hospitalization (at a rate δ). This gives
dI
dt
= αE − µH I − δ I. (7)
The population of hospitalized individuals is generated via the hospitalization of
symptomatic individuals (at rate δ). It is diminished by natural death (at rate µH ), disease-
induced death (at a rate dH ) and recovery (at a rate τ ). The case-fatality rates range from
4% to 18% (Chowers et al., 2001; Nash et al., 2001; Pepperell et al., 2003; Petersen et al.,
2003; Tsai et al., 1998) and between 15% to 29% in persons older than 70 years (Chowers
et al., 2001; Petersen et al., 2003; Tsai et al., 1998). It should be noted that, although no
specific anti-WNV treatment exists, these hospitalized individuals are offered supportive
treatment (notably intravenous fluids). The above assumptions give
dH
dt
= δ I − µH H − dH H − τ H. (8)
Hospitalized individuals who recover move into the recovered population (at rate τ ).
The recovered population is diminished by natural death (at rate µH ). It is assumed
that WNV infection induces life-long immunity in humans, so that recovered humans
do not acquire further WNV infection in the future (see Health Canada, 2003d; State of
Wisconsin, 2003). This gives
dR
dt
= τ H − µH R. (9)
3.4. Basic properties
It is easy to see from (1)–(9) that the equations for the rate of change of the total
populations of mosquitoes, birds and humans are given by
dNM
dt
= ΠM − µM NM , (10)
dNB
dt
= ΠB − µB NB − dB Bi , (11)
dNH
dt
= ΠH − µH NH − dH H, (12)
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respectively. All parameters of the model are assumed to be non-negative, with the
death rates µM , µB , µH , recruitment terms ΠM ,ΠB,ΠH and transmission coefficients
β1, β2, β3 together with the biting rates b1(NM , NB , NH ) and b2(NM , NB , NH ) positive.
Furthermore, each of the total subpopulations (NM (t), NB (t) and NH (t)) is assumed to be
positive for t = 0. Consider the region
D = {(Mu , Mi , Bu, Bi , S, E, I, H, R) ∈ R9+ : NM ≤ ΠM/µM ,
NB ≤ ΠB/µB , NH ≤ ΠH/µH }.
It can be shown that all solutions of the system starting in D remain in D for all t ≥ 0.
Thus,D is positively invariant and it is sufficient to consider solutions in D. In this region,
the usual existence, uniqueness and continuation results hold for the system.
4. Existence and stability of equilibria
4.1. Disease-free equilibrium (DFE)
4.1.1. Local stability
The model (1)–(9) has a DFE, obtained by setting the right hand sides of (1)–(9) to zero,
given by
E0 : (M∗u , M∗i , B∗u , B∗i , S∗, E∗, I ∗, H ∗, R∗)
=
(
ΠM
µM
, 0,
ΠB
µB
, 0,
ΠH
µH
, 0, 0, 0, 0
)
. (13)
It can be seen that E0 attracts the region
D0 = {(Mu , Mi , Bu, Bi , S, E, I, H, R) ∈ D : Mi = Bi = E = I = H = R = 0}.
The linear stability of E0 is governed by the basic reproduction numberR0 (Anderson and
May, 1991; Brauer and Castillo-Chavez, 2000; Hethcote, 2000), which can be found from
the next generation matrix for the system (1)–(9). Noting that the model has five infected
populations, namely Mi , Bi , E, I and H , it follows that, using the notation of van den
Driessche and Watmough (2002), the matrices F and V , for the new infection terms and
the remaining transfer terms respectively, are given in partitioned form by
F =
(
F1 0
F2 0
)
, V =
(
V1 0
0 V2
)
where
F1 =

 0 b1(N
∗
B , N
∗
M , N
∗
H )β1 N
∗
M
N∗B
b1(N∗B , N∗M , N∗H )β2 0

 , V1 =
(
µM 0
0 µB + dB
)
.
Here, F is a non-negative matrix of rank 2 and V is non-singular. It is easy to show that at
steady state, the spectral radius (dominant eigenvalue) of the non-negative matrix FV −1,
denoted by ρ(FV −1), is equal to ρ(F1V −11 ); hence, we do not need to explicitly give F2
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and V2. Thus,
R0 = ρ(FV −1) =
√
b21(N
∗
M , N
∗
B , N
∗
H )β1β2µBΠM
µ2M (µB + dB)ΠB
. (14)
The quantity R0 is the basic reproduction number of infection. Theorem 2 of van den
Driessche and Watmough (2002) gives the following stability result withR0 given by (14).
Lemma 1. For system (1)–(9), the disease-free equilibrium E0, given by (13), is locally
asymptotically stable ifR0 < 1 and unstable ifR0 > 1.
It should be noted that the Jacobian for the populations Mi , Bi , E, I, H at E0 is given
by F −V , and that ρ(FV −1) < 1 if and only if all eigenvalues of F −V have negative real
parts (i.e., F − V is a stable matrix); see Theorem 2 in van den Driessche and Watmough
(2002). Since the eigenvalues of F − V are those of F1 − V1 and −V2 (which has negative
eigenvalues −(µH + α),−(µH + δ) and −(µH + dH + τ )), it follows that F1 − V1 has
all its eigenvalues with negative real parts if and only ifR0 < 1.
Near the DFE, E0, each infective bird produces
b1(N∗M ,N∗B ,N∗H )β1µBΠM
µM (µB+dB)ΠB new infected
mosquitoes over its expected infectious period. Similarly, each infective mosquito produces
b1(N∗M ,N∗B ,N∗H )β2
µM
new infected birds over its expected infectious period. The square root
in R0 represents a geometric mean, and gives the expected number of new infections
produced by a single infective (mosquito or bird) when introduced into a susceptible
population. Note that since humans are dead-end hosts, the parameters associated with
the human dynamics only contribute intoR0 through the dependence of b1(NM , NB , NH )
on the total human population (NH ).
Biologically speaking, Lemma 1 implies that West Nile virus can be eradicated from the
mosquito–bird–human populations (whenR0 < 1) if the initial sizes of the subpopulations
of the model are in the basin of attraction of E0. To ensure that the virus eradication is
independent of the initial sizes of the subpopulations of the model, it is imperative to show
that the DFE is globally asymptotically stable as follows.
4.1.2. Global stability
In order to establish the global stability of the DFE, some assumptions are introduced for
deriving the functional forms of b1(NM , NB , NH ) and b2(NM , NB , NH ). This is primarily
based on the malaria model considered in Anderson and May (1991). It is assumed that
each mosquito bites at a certain average rate, b, and that hosts are always sufficiently in
abundance so that it is reasonable to assume that b is constant. The rate at which birds
contract WNV infection is given by the product of the average biting rate (b), the number
of mosquitoes that are currently infected (Mi ), the probability that a bite will be infectious
(β2) and the fraction of bites that go to susceptible birds, which is given by the ratio of
susceptible birds to the total number of hosts ( BuNB+NH ). Thus, the force of infection term
in (3) is given by
b1(NM , NB , NH )β2 Mi Bu
NB
= bβ2 Bu Mi
NH + NB ,
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from which it follows that
b1(NM , NB , NH ) = bNBNB + NH .
Similarly,
b2(NM , NB , NH ) = bNHNB + NH .
From now on, it will be assumed that the biting rates b1 and b2 are constants. This is
justified as follows. WNV-induced mortality in humans is negligible (Chowers et al., 2001),
so dH is assumed to be small. Recent studies (see, for instance, Komar et al., 2003) have
shown that bird mortality is quite variable; it is not entirely clear how significant WNV-
related mortality is in selected bird populations (whilst it is quite high in some species
like corvid, it is minimal in others (Eidson et al., 2001)). Thus, in line with Wonham
et al. (2004), we assume that WNV-induced mortality does not significantly impact bird
populations, i.e., dB is small.
It should be mentioned that, even with small WNV-induced mortality rates, variability
in the total population of humans and birds is still possible due to transient relaxation
to population carrying capacity. We are more interested in long term behaviour than
transient dynamics. Using Eqs. (10) and (11), it can be shown that the total bird and human
populations will, after some transition, lie in the intervals [ΠB/(µB + dB),ΠB/µB] and
[ΠH/(µH + dH ),ΠH/µH ], respectively. Thus, their variations will be quite small if dB
and dH are small. Numerical simulations of the model with small dB and dH and initial
conditions close to the DFE confirm this. Thus, we choose to ignore the transient variation,
and set
b1(NM , NB , NH ) = bN
∗
B
N∗B + N∗H
, b2(NM , NB , NH ) = bN
∗
H
N∗B + N∗H
.
It has been shown in Lemma 1 that the model has a locally asymptotically stable disease-
free equilibrium (E0) wheneverR0 < 1. We claim the following global stability result.
Theorem 1. If R0 < 1, then the disease-free equilibrium, E0 given by (13), is globally
asymptotically stable (GAS) in D.
Proof. It is clear from Appendix A that E0 is the only equilibrium of the model whenever
R0 < 1. Since all solutions remain in the positively invariant region D, it follows that
Mu(t) ≤ ΠM
µM
, Bu(t) ≤ ΠB
µB
(15)
for all t ≥ 0. Since E0 is locally asymptotically stable (Lemma 1), it suffices to show that
any solution of (1)–(9) in the ω-limit set of an orbit in D converges to the disease-free
equilibrium. Let (Mu , Mi , Bu, Bi ) be the corresponding components of such a solution. It
follows, using (11), that
NB (t) = e−µB (t−s)NB (s) +
∫ t
s
e−µB(t−θ)[ΠB − dB Bi(θ)]dθ. (16)
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Setting s → −∞ in (16) gives
NB (t) = ΠB
µB
− dB X B(t), (17)
where
X B(t) =
∫ t
−∞
e−µB (t−θ)Bi (θ)dθ. (18)
Since NB (t) > 0, it follows that dB X B(t) < ΠB/µB so that (from Eqs. (2), (4), (17) and
(18))
dX B
dt
= −µB X B + Bi ,
dMi
dt
≤ −µM Mi + b1β1ΠM
µM
(
ΠB
µB
− dB X B
) Bi ,
dBi
dt
≤ b1β2 Mi − (µB + dB)Bi .
Using a standard comparison argument (see Lakshmikantham and Leela, 1969), we only
need to show that every solution of the system
dX B
dt
= −µB X B + Bi , (19)
dMi
dt
= −µM Mi + b1β1ΠM
µM
(
ΠB
µB
− dB X B
) Bi , (20)
dBi
dt
= b1β2Mi − (µB + dB)Bi , (21)
converges to zero as t → ∞.
The system (19)–(21) is cooperative and irreducible with a unique equilibrium in the
closure of the open set
D˜ =
{
(X B, Mi , Bi ) : 0 < X B < ΠB
µBdB
, Mi > 0, Bi > 0
}
.
Thus, by Theorem 3.1 in Smith (1995, p. 18),
(X B(t), Mi (t), Bi (t)) → (0, 0, 0) as t → ∞. (22)
Since (Mi (t), Bi (t)) → (0, 0) as t → ∞, it follows that Mi (t) < 1 and Bi(t) < 2 for
large t and sufficiently small 1, 2. Thus, (1) and (3) can be expressed as
dMu(t)
dt
> ΠM − b1β12 µBΠB Mu − µM Mu , (23)
dBu(t)
dt
> ΠB − b1β21 µBΠB Bu − µB Bu. (24)
Then,
lim inf
t→∞ Mu(t) ≥
ΠM
b1β12 µBΠB + µM
, lim inf
t→∞ Bu(t) ≥
ΠB
b1β21 µBΠB + µB
. (25)
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Setting 1 → 0 and 2 → 0 gives
lim inf
t→∞ Mu (t) ≥
ΠM
µM
and lim inf
t→∞ Bu(t) ≥
ΠB
µB
. (26)
Combining (15) and (26) shows that if R0 < 1,
lim
t→∞ Mu(t) =
ΠM
µM
and lim
t→∞ Bu(t) =
ΠB
µB
. (27)
It follows from (27) and (22) that if R0 < 1, then (Mu , Mi , Bu, Bi ) → (ΠMµM , 0, ΠBµB , 0)
as t → ∞. Using (22) in (5)–(9), it can be shown that S → ΠH
µH
and (E, I, H, R) →
(0, 0, 0, 0) as t → ∞. Thus, E0 is globally asymptotically stable in D whenever
R0 < 1. 
4.2. Endemic equilibria
For (1)–(9) with b1, b2 constants, the endemic equilibrium, in which infected
compartments are non-zero, cannot easily be expressed in closed form. Details given in
Appendix A lead to the following result.
Theorem 2. The model (1)–(9) has a unique positive endemic equilibrium (denoted by E1)
ifR0 > 1 and no positive endemic equilibrium ifR0 < 1.
Linearizing Eqs. (1)–(9) around E1, and applying the Routh–Hurwitz criteria, gives the
following result (see Appendix B for proof):
Lemma 2. If µB > dB, then the unique endemic equilibrium E1 of (1)–(9) is locally
asymptotically stable wheneverR0 > 1.
Furthermore, the following global stability result can be established (see Appendix C for
proof):
Theorem 3. If dB ∈ [0, d0] for some small d0 ∈ R+ and R0 > 1, then every solution of
(1)–(9) starting in D \D0 converges to E1 as t → ∞.
5. Assessment of preventive strategies
The two main control strategies against the spread of WNV in humans are mosquito
reduction strategies and personal protection against exposure to mosquitoes. Mosquito
reduction strategies include the elimination of mosquito breeding sites (through improved
drainage and prevention of standing water), larvaciding (killing mosquito larvae before
they become adults) and adulticiding (killing adult mosquitoes via fogging) using
appropriate biological agents (Nosal and Pellizzari, 2003). Personal protection, on the
other hand, entails the use of clothing protection, insect repellents (containing DEET)
and avoiding places where mosquitoes bite (Petersen and Marfin, 2002). In order to
examine the effects of these two classes of anti-WNV strategies, the model (1)–(9) is
simulated using the set of parameter values given in Table 1. It should be mentioned that
some of these parameters (e.g. α, δ, τ ) are estimated on the basis of some published data
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Table 1
Model parameters and their interpretations
Parameter Description Estimated value
ΠM Recruitment rate of uninfected mosquitoes (per day) Variable
ΠB Recruitment rate of susceptible birds (per day) 1000
ΠH Recruitment rate of susceptible humans (per day) 30
1/µM Average lifespan of a mosquito (days) Variable
1/µB Average lifespan of a bird (days) 1000
1/µH Average lifespan of a human (days) 70 ∗ 365
q Efficacy of the personal protection 0 ≤ q ≤ 1
c Fraction of community complying with personal protection protocol 0 ≤ c ≤ 1
b1 Rate of biting of birds by mosquitoes (per day) 0.09
b2 Rate of biting of humans by mosquitoes (per day) 0.09(1 − cq)
β1 Probability of transmission from bird to mosquito 0.16
β2 Probability of transmission from mosquito to bird 0.88
β3 Probability of transmission from mosquito to human 0.88
dB WNV-induced death rate for birds (fraction per day) 5 × 10−5
dH WNV-induced death rate for humans (fraction per day) 5 × 10−7
1/α Incubation period in humans (days) 14
δ Hospitalization rate for humans (days) 1
1/τ Recovery rate for humans (days) 14
(such as Campbell et al., 2002; Petersen et al., 2003; Chowers et al., 2001; Pepperell et al.,
2003) or knowledge of the approximate lifespan of birds and mosquitoes (thereby enabling
the realistic estimation of µB , µM ). The parameter µH is taken to be 1/(70 ∗ 365) per
day, in line with the 70-year average life expectancy of humans in Canada. Following
Wonham et al. (2004) and the references therein, the transmission probabilities β1 and β2
are assigned the mean values of 0.16 and 0.88 respectively, and the rate of biting of birds
by mosquitoes is set at b1 = 0.09 per day. It is, therefore, plausible to set β3 = 0.88 and
b2 = 0.09 per day. Owing to the absence of data, some of the other parameters associated
with the model (1)–(9) (e.g. ΠB , dB , ΠH and dH ) are estimated (see Table 1). The results
obtained are reported in the following subsections.
5.1. Effect of mosquito reduction strategies
The effect of larvaciding is incorporated in our model by decreasing the recruiting
parameter, ΠM , of uninfected mosquitoes. In other words, a reduction in ΠM serves
to reduce the number of mosquitoes being born into the community, and thus can be
used to investigate the effects of larvaciding on the epidemic. Similarly, the effects of
fogging and other adulticiding methods for eliminating adult mosquitoes is modelled by
decreasing 1/µM . Furthermore, sinceR0 is an increasing function ofΠM and a decreasing
function of µM , the use of any preventive strategy that can reduce ΠM or increase µM
results in a reduction of WNV infections in the mosquito–bird cycle and, consequently,
in humans.
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Fig. 2. Basic reproduction number of infections (R0) as a function of ΠM (representing the effect of larviciding)
and mean mosquito lifespan, 1/µM (representing the effect of adulticiding). All other parameters are as shown
in Table 1.
Numerous simulations were carried out with varying values of ΠM and 1/µM , and the
results obtained are depicted in Fig. 2. It is assumed, here, that the maximum lifespan of
a mosquito is 14 days (that is, 1/µM ≤ 14 days) and the maximum number of recruited
mosquitoes is 2.2 × 104 per day (that is, ΠM ≤ 2.2 × 104). It is clear from Fig. 2 that
low efficacies of larvaciding (corresponding to higher values of mosquito birth rate ΠM )
and adulticiding (corresponding to higher mean values of mosquito lifespan 1/µM ) make
R0 > 1. The implication of this is that the disease will persist in the population. This
is owing to the fact that the endemic equilibrium is globally stable for a small rate of
WNV-induced avian mortality whenever R0 > 1 (Theorem 2). For instance, a mosquito
control strategy that allows the daily birth of 104 mosquitoes and mosquito lifespan of
at least ten days will fail to eradicate the disease in the mosquito–bird populations (since
this strategy results in R0 > 1 in Fig. 2). On the other hand, if larvaciding can ensure
that less than 4 × 103 mosquitoes are born daily, then the disease will be eradicated
regardless of the presence or absence of other control measures (in this case, R0 < 1).
Similarly, an adulticiding program that reduces the mean mosquito lifespan to at most
six days is sufficient to singly eradicate WNV from the mosquito–bird community. Fig. 3
depicts a three-dimensional plot of the combined effects of larvaciding and adulticiding
on the number of asymptomatically infected humans at steady state (E∗∗). As expected,
this figure shows that increasing the efficacies of larvaciding and adulticiding results in
a decrease in the WNV incidence in the human community (in comparison to the case
where these control measures are non-existent). Overall, this study shows that a sufficiently
effective mosquito reduction strategy, based on the use of larvaciding or adulticiding (or
their combination), can lead to the eradication of WNV in the entire mosquito–bird–human
community.
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Fig. 3. Total number of asymptomatically infected humans at steady state (E∗∗) as a function ofΠM (representing
the effects of larviciding) and mean mosquito lifespan, 1/µM (representing the effects of fogging and other adult
mosquito control strategies). All other parameters are as shown in Table 1.
5.2. Effect of personal protection
The aim here is to assess the impact of using personal protection on the control of
WNV spread in humans. Since personal protection is aimed at minimizing exposure to
mosquitoes, thereby reducing the risk of infection, it is deemed prudent to model the
effect of personal protection by rescaling the transmission coefficient, b2β3, of WNV to
humans (following mosquito bites) using b2β3 → b2β3(1 − cq), where 0 < q ≤ 1 is
the efficacy of the personal protection strategy adopted, and 0 ≤ c ≤ 1 is the fraction
of the community employing it (compliance), where c = 1 means 100% compliance and
c = 0 represents no compliance at all. The effect of personal protection is then assessed by
simulating the model in the absence of any mosquito control strategy with varying values
of c and q . Although no amount of personal protection can lead to WNV eradication in the
mosquito–bird community, higher efficacies and compliance rates of personal protection
can significantly reduce WNV incidence in humans.
5.3. Adulticiding versus personal protection
Despite the fact that personal protection strategies have no effect on the mosquito–bird
amplifying WNV reservoir, they can serve to reduce the number of humans becoming
infected. We, consequently, seek to compare the effects of adulticiding (fogging) and
personal protection on the control of the spread of West Nile virus in humans. The results,
depicted in Fig. 4, show a marked increase in the number of asymptotically infected
humans at steady state with increasing non-compliance of personal protection (smaller
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Fig. 4. Total number of exposed, infected and hospitalized humans at steady state (E∗∗+ I∗∗+H ∗∗) as a function
of mean mosquito lifespan, 1/µM . This solid curve represents the effects of adulticiding, which is plotted on the
bottom axis, in the absence of personal protection strategies (c = q = 0). The dotted and dashed curves represent
the fraction of people not using personal protection measures (1 − c), as shown on the top axis, at q = 0.7
(70% efficacy) and q = 1 (100% efficacy) respectively with 1/µM = 14 days (which represents the absence of
adulticiding). All other parameters are as shown in Table 1.
values of c) and mean mosquito lifespan. On the other hand, the use of personal protection
with high efficacy reduces the number of cases in humans. For instance, if 90% of the
human population use personal protection (c = 0.9), then the number of asymptomatically
infected humans will be 845 if the personal protection is 70% effective and 792 if the
efficacy is 100%. Although this clearly shows that the efficacy of personal protection
is important, Fig. 4 also shows that in addition to high efficacy of personal protection
strategies, high compliance is necessary for such strategies to make meaningful impact in
combatting WNV in humans. Furthermore, this figure shows that adulticiding can be more
effective in reducing the number of infections in humans than personal protection.
6. Summary and future refinements
This paper is based on the design and use of a new model for the transmission dynamics
of WNV in a mosquito–bird–human community. The model, which incorporates essential
elements of WNV transmission, enables the assessment of various anti-WNV preventive
strategies. On the basis of the parameter values used in our simulations, our study shows
that:
(i) In the absence of recruitment of infected birds or mosquitoes into the community,
WNV can be eradicated from the entire mosquito–bird–human community using
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Fig. 5. Graphical representation of the unique endemic equilibrium on the Mi , Bi plane when R0 > 1.
(a) B∗i1 ≤ 0, (b) B∗i1 > 0.
sufficiently effective mosquito reduction strategies alone. This finding is consistent
with the claim in (Wonham et al., 2004) that a 40–70% reduction in the initial
population of mosquitoes would have prevented the WNV outbreak in New York in
2000.
(ii) On average, adulticiding is a more effective preventive strategy for controlling WNV
spread in humans in comparison to the use of personal protection.
(iii) WNV incidence in humans increases with increasing mean mosquito lifespan, and
if the mean mosquito lifespan is large enough, then personal protection is of little
significance in combatting WNV spread in humans unless it has very high efficacy
and compliance rate.
As more biological facts on WNV become known, our mathematical model should
be refined. For instance, it had been thought that WNV was only transmitted through
mosquito bites. However, studies from the U.S. Geological Survey (2003) and those in
Komar et al. (2001b,a, 2003) show that WNV can be transmitted from bird to bird in a
confined laboratory setting. Hence, it is worthwhile to investigate the effect of bird-to-bird
transmission of WNV. One other effect is that freshly dead WNV-infected birds may still
transmit the virus to mosquitoes that feed on them within the short window (on a timescale
of a few hours). These factors could enhance WNV reservoirs in birds and the ability of
amplification/transmission of the virus.
Our model considers WNV transmission among mosquitoes, birds and humans,
by considering the dynamics in an isolated patch (one single mosquito–bird–human
community); the effect of seasonality and migration of birds are not accounted for. These
are important factors since, for non-tropical regions, the cold season signals the end of
the epidemic season, while the heterogeneity and migration of birds from region to region
plays a key role in the viral amplification process. It is feasible that infected birds can
migrate from one region to another. This fact can be incorporated in our model by assuming
that a proportion (p) of recruited birds (ΠB) are infected. That is, a proportionΠB(1 − p)
of recruited birds are susceptible whilst the remaining fraction (ΠB p) is infected. The
consequence of this (recruitment of infected birds) is that the disease-free equilibrium
(E0) does not exist any longer. Thus, no amount of preventive measures can eradicate
WNV from the mosquito–bird–human community (although these measures can lead to
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significant reductions in WNV infections). The effect of seasonality can be incorporated
by using time-dependent transmission coefficients.
One other way to extend our study is to relax our assumption of constant biting rates (b1
and b2), which relied on simulations around the disease-free equilibrium with small WNV-
induced avian and human mortality levels, and carry out a rigorous mathematical analysis
of the resulting model (with time varying biting rates b1 and b2 as defined in Section 4.1.2).
Overall, in addition to showing that WNV can be controlled in a human population
using a mosquito reduction strategy alone, our study establishes the global dynamics of a
relatively large non-linear dynamical system.
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Appendix A. Proof for the uniqueness of the endemic equilibrium
In this appendix, a proof for the existence of a unique endemic equilibrium for
the model (1)–(9) (with b1, b2 constants) is given. First consider the equations for the
mosquito–bird–mosquito cycle (1)–(4). Adding Eqs. (1) and (2) gives, at steady state,
Mu = ΠM
µM
− Mi . (A.1)
Similarly, adding Eqs. (3) and (4) leads to
Bu = ΠB
µB
−
(
1 + dB
µB
)
Bi . (A.2)
It is clear from (A.1) and (A.2) that Bu ≥ 0 and Mu ≥ 0 if Bi ≤ B∗i2 = ΠBµB+dB and
Mi ≤ M∗i = ΠMµM respectively. Hence, to ensure that all the state variables are non-negative,
we restrict to (Bi , Mi ) ∈ [0, B∗i2] × [0, M∗i ].
Substituting (A.1) into (2) with NB from (11) gives the following curve:
Mi =
b1β1ΠM
µM
Bi
ΠB
µB
µM +
(
b1β1 − µM dBµB
)
Bi
= Γ1(Bi ). (A.3)
Clearly, Γ1(0) = 0 and the slope of Γ1 at (Mi , Bi ) = (0, 0) is mΓ1 = b1β1µBΠMµ2MΠB .
Furthermore, from (A.3), if µM dB = b1β1µB , Γ1 has a vertical asymptote given by
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Bi = B∗i1, where B∗i1 = µMΠBµM dB−b1β1µB , and B∗i1 can be positive or negative (see Fig. 5).
If µM dB = b1β1µB , Γ1 is reduced to a straight line through the origin with slope mΓ1 , the
case included in the scenario B∗i1 < 0.
Substituting (A.2) into (4) with NB from (11) gives
Mi = (ΠB − dB Bi )Bi
b1β2
(
ΠB
µB+dB − Bi
) = Γ2(Bi ). (A.4)
Note that Γ2 has a vertical asymptote at Bi = B∗i2. Although the curveΓ2 has two branches,
only the branch situated to the left of B∗i2 is of interest. Furthermore, the slope of Γ2 at the
origin is mΓ2 = µB+dBb1β2 . For the cases B∗i1 ≤ 0 and B∗i1 > 0, it follows from Fig. 5(a) and(b) that a unique endemic equilibrium exists if and only if mΓ1 > mΓ2 . Hence, a unique
endemic equilibrium exists if and only if R0 > 1.
To ensure that the unique intersection of the curves Γ1 and Γ2 leads to a positive
equilibrium, we only need to verify Mi ≤ M∗i . Clearly, since Bi < B∗i2, it follows that
Bi < ΠBµB+dB <
ΠB
dB . Therefore it follows from (A.3) that
Mi =
b1β1ΠMµM Bi
b1β1 Bi + µM dBµB
(
ΠB
dB − Bi
) < b1β1ΠMµM Bi
b1β1 Bi
= ΠM
µM
. (A.5)
Thus, the subsystem (1)–(4) has a unique endemic equilibrium with Bi = B∗∗i ∈ (0, B∗i2).
This value can now be obtained in closed form as follows. Equating the right hand sides of
(A.3) and (A.4) and simplifying gives (for Bi = 0) the following quadratic:
a2(B∗∗i )2 + a1 B∗∗i + a0 = 0, (A.6)
where
a2 = dB(µM dB − b1β1µB)b1β2µB , (A.7)
a1 = b1β1ΠM
µM
− (2µMdB − b1β1µB)
b1β2µB
ΠB, (A.8)
a0 = µMΠ
2
B(1 −R20)
b1β2µB
. (A.9)
Solving for B∗∗i from (A.6) enables the other variables (M∗∗i , B∗∗u and M∗∗u ) to be computed
from (A.3), (A.2) and (A.1), respectively. From (5)–(9) at an equilibrium, the variables
S, I, H , and R (and thus NH ) can be expressed in terms of the variable E . Substituting
these into (2) and using the unique value of M∗∗i , results in a quadratic for E , which has
exactly one root E∗∗ in the biologically meaningful range 0 < E∗∗ < ΠH/(µH +α). This
gives a unique value for each of the other human components, giving a unique endemic
equilibrium for the full system:
E1 := (M∗∗u , M∗∗i , B∗∗u , B∗∗i , S∗∗, E∗∗, I ∗∗, H ∗∗, R∗∗).
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Appendix B. Proof for the local stability of the endemic equilibrium
Since humans do not feed back into the mosquito–bird cycle, the Jacobian of the whole
system is reducible, with eigenvalues given by those of the subsystem (1)–(4) together with
those of the human subsystem (5)–(9). Evaluating the Jacobian of (1)–(4) at E1 gives
J =

− b1β1 B
∗∗
i
B∗∗i + B∗∗u
− µM 0 b1β1 M
∗∗
u B∗∗i
(B∗∗i + B∗∗u )2
b1β1 M∗∗u B∗∗i
(B∗∗i + B∗∗u )2
− b1β1 M
∗∗
u
B∗∗i + B∗∗u
b1β1 B∗∗i
B∗∗i + B∗∗u
−µM − b1β1 M
∗∗
u B∗∗i
(B∗∗i + B∗∗u )2
− b1β1 M
∗∗
u B∗∗i
(B∗∗i + B∗∗u )2
+ b1β1 M
∗∗
u
B∗∗i + B∗∗u
0 − b1β2 B
∗∗
u
B∗∗i + B∗∗u
b1β2 M∗∗i B∗∗u
(B∗∗i + B∗∗u )2
− b1β2 M
∗∗
i
B∗∗i + B∗∗u
− µB b1β2 M
∗∗
i B
∗∗
u
(B∗∗i + B∗∗u )2
0
b1β2 B∗∗u
B∗∗i + B∗∗u
− b1β2 M
∗∗
i B
∗∗
u
(B∗∗i + B∗∗u )2
+ b1β2 M
∗∗
i
B∗∗i + B∗∗u
− b1β2 M
∗∗
i B
∗∗
u
(B∗∗i + B∗∗u )2
− µB − dB


,
from which it follows that the eigenvalues of J are −µM and the roots of
λ3 + a1λ2 + a2λ + a3 = 0
where
a1 =
b1β1 B∗∗i + µM B∗∗i + 2µB B∗∗i + dB B∗∗i + b1β2 M∗∗i + dB B∗∗u + 2µB B∗∗u + µM B∗∗u
B∗∗i + B∗∗u
a2 = 1
(B∗∗i + B∗∗u )2
[(µM dB + b1β1dB + 2b1β1µB + µBdB + 2µBµM + µ2B)
× (B∗∗i )2 + (4 µBµM + 2 µ2B + 2µBdB + b1β1dB + 2 b1β1µB + 2µM dB)× B∗∗u B∗∗i + b1β2(b1β1 + µB + µM + dB)M∗∗i B∗∗i + (µM dB + 2 µBµM
+µ2B + µBdB)(B∗∗u )2 + (−b2β2β1 M∗∗u + b1β2(µB + µM )M∗∗i )B∗∗u ]
a3 = 1
(B∗∗i + B∗∗u )3
[β1β2(dB B∗∗i + µB B∗∗i + µB B∗∗u )(M∗∗i B∗∗i − B∗∗u M∗∗u )b21
+ ((B∗∗i + B∗∗u )µMβ2(dB B∗∗i + µB B∗∗i + µB B∗∗u ))b1 M∗∗i
+ (B∗∗i + B∗∗u )2β1 B∗∗i µB(µB + dB)b1 + µMµB(B∗∗i + B∗∗u )3(µB + dB)].
Clearly, a1 > 0. The next task is to determine the signs of a2 and a3. It is easy to see
that Eq. (14) can be rewritten in terms of β2 as
β2 = R
2
0µ
2
M (µB + dB)ΠB
ΠMµBb2β1
. (B.1)
Solving the quadratic equation (A.6) forR20 in terms of B∗∗i gives
R20 =
µM (ΠB − db B∗∗i )2 + µBb1β1 B∗∗i (ΠB − dB B∗∗i )
µMΠB(ΠB − (µB + dB)B∗∗i )
. (B.2)
Substituting the expressions for the model variables ((A.1)–(A.3)) at the endemic
equilibrium and (B.1) and (B.2) into the expressions for a2 and a3 and collecting terms
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in b1 and β1 respectively gives
a2 = b1 B
∗∗
i β1µB[(µB + dB)(ΠB − (µB + dB)B∗∗i ) + ΠBµB]
(ΠB − dB B∗∗i )(ΠB − (µB + dB)B∗∗i )
+ µB[ΠB(ΠB − dB B
∗∗
i )µM + (µB + dB)((ΠB − dB B∗∗i )2 + (B∗∗i )2µBdB)]
(ΠB − dB B∗∗i )(ΠB − (µB + dB)B∗∗i )
a3 = b1β1µ
2
B(µB + dB)B∗∗i ((ΠB − dB(B∗∗i )2 + (B∗∗i )2µBdB))
(ΠB − dB B∗∗i )2(ΠB − (µB + dB)B∗∗i )
+ (ΠB(µB − dB) + d
2
B B
∗∗
i + B∗∗i µBdB)µMµB(µB + dB)B∗∗i
(ΠB − (µB + dB)B∗∗i )(ΠB − dB B∗∗i )
.
It is easy to see that a2 and a3 are both positive if
B∗∗i <
ΠB
(µB + dB) <
ΠB
dB
, µB > dB . (B.3)
The first of these conditions is required for the positivity of Bu . The second is biologically
reasonable.
The remaining task associated with the Routh–Hurwitz criteria is to show that a1a2 −
a3 > 0. It can be shown, following extensive manipulations, that a1a2 − a3 can be written
in terms of the following quadratic:
D2b21 + D1b1 + D0, (B.4)
with
D2 =
((
ΠB − (µB + dB)B∗∗i
)
(dB + µB) +ΠBµB
)
β21 (B
∗∗
i )
2µ2B
(ΠB − dB B∗∗i )2(ΠB − (µB + dB)B∗∗i )
D1 = µBβ1 B
∗∗
i µM
(
(dB + µB)
(
ΠB − (dB + µB) B∗∗i
)+ 2ΠBµB)(
ΠB − dB B∗∗i
)
(ΠB − (dB + µB) Bi )
+ µBβ1 B
∗∗
i
(
(dB + µB)
(
ΠB − (dB + µB) B∗∗i
)+ΠBµB)2(
ΠB − dB B∗∗i
) (
ΠB − (dB + µB) B∗∗i
)2
D0 = µ
2
MµBΠB
ΠB − (dB + µB) B∗∗i
µ2M
+
(
(µB + 2 dB)
(
ΠB − (µB + dB) B∗∗i
)2 + 2 µBΠB (ΠB − (µB + dB) B∗∗i ) +ΠBµ2B B∗∗i )ΠBµB(
ΠB − dB B∗∗i
) (
ΠB − (µB + dB) B∗∗i
)2
×µM
µB (dB + µB)
(
(dB + µB)
(
ΠB − (dB + µB) B∗∗i
)+ΠBµB) ((ΠB − dB Bi )2 + B∗∗2i µBdB)(
ΠB − dB B∗∗i
) (
ΠB − (dB + µB) B∗∗i
)2 .
Eq. (B.4) is clearly positive provided the inequalities in (B.3) are satisfied. Thus,
a1a2 − a3 > 0 provided (B.3) hold.
For the human subsystem, taking variables S, I, H, R and NH , the eigenvalues are −µH
and the roots of the polynomial
(λ + µH + dH + τ )(λ + µH + δ)(λ + µH + α)(λ + µH + b2β3M∗∗i /N∗∗H )
− dHδαb2β3M∗∗i S∗∗/N∗∗H = 0.
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The constant term in the above polynomial is positive, and the Routh–Hurwitz conditions
show that all eigenvalues have negative real parts, completing the proof that E1 is locally
asymptotically stable provided that µB > dB andR0 > 1.
Appendix C. Proof for the global stability of the endemic equilibrium
It is easy to show that each of the variables Mu(t), Mi (t), Bu(t) and Bi(t) remains
positive for all t > 0 as long as 0 ≤ NM (0) ≤ ΠMµM , 0 ≤ NB (0) ≤ ΠBµB and
(Mi (0), Bi (0)) = 0.
Firstly, consider the case with dB = 0. Eqs. (10) and (11) now become
dNM (t)
dt
= ΠM − µM NM ,
dNB(t)
dt
= ΠB − µB NB .
We want to show that a solution in the ω-limit set of a given trajectory of (1)–(4)
converges to E˜1, the component of E1 associated with the subsystem (1)–(4) with dB = 0,
as t → ∞. Let X (t) = (Mu(t), Mi (t), Bu(t), Bi (t)) be such a solution. Then it is defined
for all t ∈ R and is bounded for all t ∈ R. Integrating the above equations from s to t and
letting s → −∞ gives
Mi = ΠM
µM
− Mu and Bi = ΠB
µB
− Bu . (C.1)
We emphasize that (C.1) holds only for the solutions that are defined and bounded for all
t ∈ R. In particular, (C.1) holds for solutions that pass through the ω-limit set of every
given bounded solution of (1)–(4). For these solutions that are defined and bounded for all
t ∈ R, we can then substitute (C.1) into (2) and (4) to obtain

dMi (t)
dt
= b1β1 µBΠB
(
ΠM
µM
− Mi
)
Bi − µM Mi ,
dBi (t)
dt
= b1β2 µBΠB
(
ΠB
µB
− Bi
)
Mi − µB Bi .
(C.2)
Γ = {(Mi , Bi ) : 0 ≤ Mi ≤ ΠMµM , 0 ≤ Bi ≤ ΠBµB }. Inside this region, the system(C.2) generates a strongly order-preserving flow and has two equilibria, namely (0, 0) and
(M∗∗i , B∗∗i )|dB=0. Since (0, 0) is unstable and (M∗∗i , B∗∗i )|dB=0 is locally asymptotically
stable, the theory of monotone dynamical systems (see Smith, 1995, Theorem 2.2, p. 17)
then ensures that Mi (t) → M∗∗i |dB=0 and Bi(t) → B∗∗i |dB=0 as t → ∞ provided
(Mi (0), Bi (0)) = (0, 0).
We now claim that if dB = 0, then it is impossible for X (t) → E˜0 (where E˜0 represents
the components of E0 associated with (1)–(4) with dB = 0) as t → ∞. If X (t) → E˜0,
then for small  > 0, there exists T > 0 such that
ΠM
µM
−  ≤ Mu(t) ≤ ΠM
µM
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ΠB
µB
−  ≤ Bu(t) ≤ ΠB
µB
for all t ≥ T . Therefore, Eqs. (2) and (4) can now be expressed in the matrix–vector
inequality form:

dMi (t)
dt
dBi(t)
dt

 ≥ Q [MiBi
]
with Q =


−µM b1β1µBΠB
(
ΠM
µM
− 
)
b1β2µB
ΠB
(
ΠB
µB
− 
)
−µB

 .
Since R0 > 1 (needed for the existence and local stability of E1), it follows that for
sufficiently small  > 0, the matrix Q has a positive real eigenvalue, say α, with associated
eigenvector u ∈ R2 that has both components positive. Since Mi (T ) > 0 and Bi(T ) > 0,
there exists  > 0 small so that Mi (T ) > u1 and Bi (T ) > u2. Thus, a standard
comparison argument (Lakshmikantham and Leela, 1969) leads to
(Mi (t), Bi (t))T ≥ eα(t−T )(u1, u2)T → ∞. (C.3)
Clearly, the inequality (C.3) contradicts (Mi (t), Bi (t)) → 0 as t → ∞. Thus, X (t) cannot
approach E˜0 as t → ∞ for dB = 0.
We can now show that if dB = 0, then X (t) → E˜1 as t → ∞ if 0 ≤ NM (0) ≤
ΠM
µM
, 0 ≤ NB (0) ≤ ΠBµB and Mi (0) + Bi (0) = 0. This is because the above discussions
show that there must be a full trajectory, in the ω-limit set of X (t), that is not the
equilibrium E˜0 and must converge to E˜1 as t → ∞. Note that E˜1 is asymptotically stable
and the above trajectory must enter the basin of attraction of E˜1. Using the continuity of
solutions with respect to initial values, we conclude that X (t) must enter the domain of
attraction of E˜1 and hence X (t) converges to E˜1 as t → ∞.
Now consider the general case with dB > 0 but small. For this case, the analysis
will be based on using a regular perturbation argument together with Liapunov function
theory as follows. Let X (t) be as above, namely a solution of (1)–(4) with dB = 0,
and let Y (t) = (Mu(t), Mi (t), Bu(t), Bi (t)) be a solution of (1)–(4) with dB > 0 and
(Mi (0), Bi (0)) = 0. Furthermore, let X (0) = Y (0), let F(X) denote the vector field of
(1)–(4) with dB = 0 and g(Mu, Mi , Bu, Bi ) = (0, 0, 0, Bi). Let J (X) be the Jacobian of
F evaluated at X . Note that F(X) and J (X) are bounded in the region 0 ≤ NM ≤ ΠM/µM
and 0 ≤ NB ≤ ΠB/µB . Then,
dX
dt
= F(X),
dY
dt
= F(Y ) − dB g(Y ).
We want to show that |X (t) − Y (t)| can be made arbitrarily small uniformly for all t ≥ 0
if dB is small.
Let Y = X + dB Z with Z(0) = 0 and dB > 0. Then,
dX (t)
dt
+ dB dZ(t)dt = F(X + dB Z) − dB g(X + dB Z)
= F(X) +
∫ 1
0
J (X + θdB Z)dB Zdθ − dB g(X + dB Z). (C.4)
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So, since dB > 0,
dZ(t)
dt
=
∫ 1
0
J (X + θdB Z)Zdθ − g(X + dB Z). (C.5)
Thus,
dZ(t)
dt
=
∫ 1
0
[J (X) + J (X + θdB Z) − J (X)]Zdθ − g(X + dB Z)
= J (X)Z +
∫ 1
0
[J (X + θdB Z) − J (X)]Zdθ − g(X + dB Z)
= J (E˜1)Z + [J (X) − J (E˜1)]Z
+
∫ 1
0
[J (X + θdB Z) − J (X)]Zdθ − g(X + dB Z).
(C.6)
Since E˜1 is asymptotically stable for the system (1)–(4), there exists a positive definite
matrix C such that
C J (E˜1) + (J (E˜1))T C = −I4×4. (C.7)
Therefore, L(Z) = Z T C Z is a Liapunov function for the linearized system of (1)–(4) at
E˜1 when dB = 0. Choose constants α2 ≥ α1 > 0 so that α1 Z T Z ≤ L(Z) ≤ α2 Z T Z . Note
that X (t) → E˜1 as t → ∞, and that J (X) is uniformly Lipschitz and g(X) is bounded
in the region where 0 ≤ NM ≤ ΠM/µM and 0 ≤ NB ≤ ΠB/µB . Therefore, there exist
T ≥ 0 and constants k1, k2, d0 > 0 so that for t ≥ T and for all dB ∈ [0, d0],
dL(Z(t))
dt
≤ −1
2
Z T Z + dBk1 Z T Z + k2
√
Z T Z
≤ −1
2
Z T Z + dBk1
α1
L(Z) + k2√
α1
√
L(Z)
≤ −
(
1
2α2
− dBk1
α1
)
L(Z) + k2√
α1
√
L(Z)
= √L(Z) [−( 1
2α2
− dBk1
α1
)√
L(Z) + k2√
α1
]
.
(C.8)
Thus,
L(Z(t)) ≤ max

L(Z(T )),

 k2√
α1
(
1
2α2 −
dBk1
α1
)


2

 . (C.9)
It is easy to show from (C.5) that L(Z(T )) is uniformly bounded for all small dB > 0.
Therefore, if d0 is small, then supt≥0 Z(t) is uniformly bounded for all dB ∈ [0, d0].
We now complete the proof for the subsystem (1)–(4) by first noting that if we write
R0 = R0(dB), thenR0(dB) > 1 for small dB if and only ifR0(0) > 1 (this follows since
R0 is a decreasing function of dB). Using the standard argument for linearized stability
(see Verhulst, 1990, pp. 88–90), if dB is small, then there exists a δ0 > 0 (independent
of dB ∈ [0, d0]) so that if |Y (0) − Eˆ1| < δ0, where Eˆ1 is the corresponding component
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of E1, then Y (t) → Eˆ1 as t → ∞. Recall if Mi (0) + Bi (0) = 0, then X (t) → E˜1 as
t → ∞. Let T ∗ > 0 be given so that |X (T ∗) − E˜1| < 12δ0, and choose d0 > 0 so small
that dB supt≥0 |Z(t)| < 14δ0 and |Eˆ1 − E˜1| < 14δ0 if dB ∈ [0, d0]. Then
|Y (T ∗) − Eˆ1| ≤ |Y (T ∗) − X (T ∗)| + |X (T ∗) − E˜1| + |Eˆ1 − E˜1| < δ0.
Hence, for the subsystem (1)–(4), Y (t) → Eˆ1 as t → ∞.
To establish global stability of E1, we need to also consider the human components
of E1. We provide a technique for doing so as follows. Using the change of variables
X H = NH + dHτ R, X1 = S + E and X2 = S + E + I = X1 + I , Eqs. (5)–(9) with (12)
can now be written as
dX H
dt
= ΠH − µH X H (C.10)
dX1
dt
= ΠH − (µH + α)X1 + αS (C.11)
dX2
dt
= ΠH − (µH + δ)X2 + δX1 (C.12)
dS
dt
= ΠH − b2β2 Mi SNH − µH S (C.13)
dNH
dt
= ΠH − (µH + dH + τ )NH + dH X2 + τ X H . (C.14)
Let (X˜ H , X˜1, S˜, N˜H , X˜2) be a solution of (C.10)–(C.14) in the ω-limit set of a given
solution of (X H , X1, S, NH , X2). Since Mi (t) → M∗∗i and X H (t) → ΠHµH as t → ∞, it
follows that
dX˜1
dt
= ΠH − (µH + α)X˜1 + α S˜ (C.15)
dS˜
dt
= ΠH − b2β2M
∗∗
i S˜
N˜H
− µH S˜ (C.16)
dN˜H
dt
= ΠH − (µH + dH + τ )N˜H + dH X˜2 + τ ΠH
µH
(C.17)
dX˜2
dt
= ΠH − (µH + δ)X˜2 + δ X˜1. (C.18)
The system (C.15)–(C.18) is a cooperative irreducible system (see Smith, 1995) in the
region
R
4+ = {(X˜1, S˜, N˜H , X˜2)T : X˜1, S˜, N˜H , X˜2 > 0}
and its closure R4+ has only one equilibrium (X˜∗1 , S˜∗, N˜
∗
H , X˜
∗
2) = (S∗∗ + E∗∗, S∗∗,
N∗H , S∗∗ + E∗∗ + I ∗∗). Therefore, by Theorem 3.1 in Smith (1995, p. 18) we conclude
that
(X˜1(t), S˜(t), N˜H (t), X˜2(t)) → (X˜∗1 , S˜∗∗, N˜∗H , X˜∗2) as t → ∞.
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This, together with the local asymptotic stability of (X˜∗1 , S˜∗∗, N˜∗H , X˜∗2), then implies that
(X H (t), X1(t), S(t), NH (t), X2(t)) → (X∗H , X∗1 , S∗∗, N∗H , X∗2) as t → ∞,
completing the proof.
Unfortunately, our proof does not yield an explicit estimation for the minimal dB for
which the global stability of E1 holds. In fact, we believe the global stability of E1 holds
for all dB > 0.
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